Retinal Medicine Clinical Research Awards
Award established to encourage independent clinical research in the field of retinal medicine across Europe
Colin Kerr
Published: Friday, September 6, 2019
[caption id="attachment_16358" align="alignleft" width="1024"]
Frank Holz (left) and Sebastian Wolf present Camiel Boon (centre) with a certificate for his clinical research award[/caption]
Education has always been high on the agenda for EURETINA and this year the society has taken a major step by investing heavily in research.
“The introduction of the EURETINA Retinal Medicine Clinical Research Funding Call provides grant opportunities to EURETINA members of up to €300,000,” said Professor Sebastian Wolf, President of EURETINA. “Its goal is to encourage independent clinical research in the field of retinal medicine across Europe, and the high volume of applications received confirms that this is indeed a vital need,” said Prof Wolf.
“Applications were reviewed by an external panel of eminent judges and it is my great pleasure to be able to announce today the recipients of this grant award."
Applications were reviewed by an external panel of eminent judges and the recipients of the grant awards are Camiel Boon, the Netherlands, for “Juvenile X-Linked Retinoschisis” and Roy Schwartz, UK, for “Reticular Pseudodrusen”.
Applications for the 2020 Call will open in November 2019 at www.euretina.org
Frank Holz (left) and Sebastian Wolf present Camiel Boon (centre) with a certificate for his clinical research award[/caption]
Education has always been high on the agenda for EURETINA and this year the society has taken a major step by investing heavily in research.
“The introduction of the EURETINA Retinal Medicine Clinical Research Funding Call provides grant opportunities to EURETINA members of up to €300,000,” said Professor Sebastian Wolf, President of EURETINA. “Its goal is to encourage independent clinical research in the field of retinal medicine across Europe, and the high volume of applications received confirms that this is indeed a vital need,” said Prof Wolf.
“Applications were reviewed by an external panel of eminent judges and it is my great pleasure to be able to announce today the recipients of this grant award."
Applications were reviewed by an external panel of eminent judges and the recipients of the grant awards are Camiel Boon, the Netherlands, for “Juvenile X-Linked Retinoschisis” and Roy Schwartz, UK, for “Reticular Pseudodrusen”.
Applications for the 2020 Call will open in November 2019 at www.euretina.org
Tags: EURETINA Clinical Research Award
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.